One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Below, we break down when the Fisch New Years Countdown event starts, how long it runs for, and what to expect from it ...

Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...

AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...

On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...

Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...

A major evolutionary theory says most genetic changes don’t really matter, but new evidence suggests that’s not true. Researchers found that helpful mutations happen surprisingly often. The twist is ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia.

The “super flu” behind outbreaks in the US and UK is a new variant of influenza A H3N2, subclade K. Existing vaccines appear ...